Norstella unites market-leading companies that all have a shared goal of improving patient access.
Each of it’s brands (Evaluate, MMIT, Panalgo, The Dedham Group) delivers must-have answers for critical strategic and commercial decision-making. Together, they help clients:
- Assess the market need and competitive landscape
- Know precisely which drugs to prioritize in their portfolios
- Find out where the launch difficulties will be—before they’re difficulties
- Track and improve market access post-launch
By combining the efforts of each organization under Norstella, they can offer breadth of expertise, cutting-edge data solutions and expert advisory services alongside advanced technologies such as real-world data, machine learning and predictive analytics.